Search Results - "Basté Rotllán, Neus"

Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer by Rotllan, Neus Basté

“…In this article, we focus on a variety of immunosuppression scenarios and whether multikinase inhibitors, as systemic therapy for advanced thyroid carcinoma…”
Get full text

Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma by Du, Chengrun, Blanchard, Pierre, Even, Caroline, Boros, Angela, Gorphe, Philippe, Breuskin, Ingrid, Baste‐Rotllan, Neus, Nguyen, France, Ruffier, Amandine, Bidault, François, Billard, Camélia, Janot, François, Mirghani, Haitham, Temam, Stephane, Tao, Yungan

“…Background The treatment outcomes for N3 HNSCC treated with induction chemotherapy (ICT) followed by definitive radiation were reported to clarify the role of…”
Get full text

Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy (NIVOTAX): A TTCC study by Iglesias, Lara, Carral, Alberto, Oliva Bernal, Marc, Martinez-Trufero, Javier, García Castaño, Almudena, Gutierrez Calderon, Vanesa, Cirauqui, Beatriz, Medina, Ana, Arrazubi, Virginia, Bruixola, Gema, Perez, Pedro, Basté Rotllán, Neus, Alvarez, Ruth, Basterretxea, Laura, Rubió-Casadevall, Jordi, Caballero Daroqui, Javier, Martínez-Galán, Joaquina, Lambea- Sorrosal, Julio Jose, del Barco, Edel, Mesia, Ricard

“…Abstract only TPS6086 Background: Nivolumab is the standard of care for patients (pts) with R/M HNSCC in the platinum-refractory setting. Up to 20% of R/M…”
Get full text

Genetic profiling across multiple cancer types using molecular prescreening comprehensive gene panels offered by clinical trials (CT) by Victoria, Iván, Moreno Fernandez, Debora, Angelats, Laura, Indacochea, Alberto, Pelegrín, Francisco, Sole i Bentz, Pol, Gaba, Lydia, Mellado, Begona, Pineda, Estela, Sauri, Tamara, Esposito, Francis, Ferrer-Mileo, Laura, Oliveres, Helena, Muñoz, Montserrat, Vidal, Maria, Martinez Saez, Olga, Basté Rotllán, Neus, Vinolas, Nuria, Nogue, Miquel, Garcia-Corbacho, Javier

“…Abstract only 3060 Background: Genetic profiling (GP) is essential not only for understanding tumor biology but also helps to identify potential genes for…”
Get full text

Abstract 5001: Open-label, non-randomized, exploratory pre-operative window-of-opportunity trial to investigate the pharmacokinetics and pharmacodynamics of the smac mimetic Debio 1143 in patients with resectable squamous cell carcinoma of the head and neck by Gomez-Roca, Carlos, Even, Caroline, Tourneau, Christophe Le, Rotllan, Neus Basté, Delord, Jean-Pierre, Sarini, Jerome, Vergez, Sebastien, Teman, Stephane, Hoffmann, Caroline, Rochaix, Philippe, Gavillet, Bruno, Rouits, Elisabeth, Brichory, Franck, Rechavi-Robinson, Dalit, Bize, Vincent, Rizzo, Sebastien Del, Purcea, Daniela, Brienza, Silvano, Zanna, Claudio, Vuagniaux, Gregoire, Szyldergemajn, Sergio

“…Background: Inhibitor of Apoptosis Proteins (IAPs) regulate apoptosis and modulate NFκB signaling, which in turn drives the expression of genes involved in…”
Get full text

Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck by Saleh, Khalil, Daste, Amaury, Martin, Nicolas, Pons-Tostivint, Elvire, Auperin, Anne, Herrera-Gomez, Ruth Gabriela, Baste-Rotllan, Neus, Bidault, Francois, Guigay, Joel, Le Tourneau, Christophe, Saada-Bouzid, Esma, Even, Caroline

“…Immune checkpoint inhibitors (ICI) are active in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Recent data…”
Get full text